JWD Subscribe to eTOC alerts
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Journal of Wildlife Diseases, 42(3), 2006, pp. 663-666
© Wildlife Disease Association  2006
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Blanton, J. D.
Right arrow Articles by Rupprecht, C. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Blanton, J. D.
Right arrow Articles by Rupprecht, C. E.

SHORT COMMUNICATION

Vaccination of Small Asian Mongoose (Herpestes javanicus) Against Rabies

Jesse D. Blanton1,4, Anastasia Meadows1, Staci M. Murphy1, Jamie Manangan1, Cathleen A. Hanlon1, Marie-Luise Faber2, Bernhard Dietzschold3 and Charles E. Rupprecht1

1 Centers for Disease Control and Prevention, 1600 Clifton Road, Atlanta, Georgia, 30333, USA;
2 Molecular Targeting Technologies, Inc., West Chester, Pennsylvania, USA;
3 Thomas Jefferson University, Philadelphia, Pennsylvania, USA
4 Corresponding author (email: asi5{at}cdc.gov)

ABSTRACT:   Oral vaccination of free-ranging wildlife is a promising technique in rabies control. The small Asian mongoose (Herpestes javanicus) is an important reservoir of rabies on several Caribbean islands, but no vaccines have been evaluated for this species. Captive mongooses were used to test the safety and efficacy of the commercially licensed vaccinia-rabies glycoprotein (V-RG) recombinant vaccine and a newly developed genetically engineered oral rabies virus vaccine (SPBNGA-S). In one study using V-RG, no vaccinated animals developed detectable rabies virus–neutralizing antibodies, and all but one died after experimental challenge with rabies virus. In contrast, all animals given SPBNGA-S demonstrated seroconversion within 7 to 14 days after vaccination and survived rabies virus challenge. On the basis of these preliminary results indicating the greater efficacy of SPBNGA-S vs. V-RG vaccine, additional investigations will be necessary to determine the optimal dose and duration of vaccination, as well as incorporation of the SPBNGA-S vaccine into edible bait.
  Key words:  Herpestes javanicus, mongoose, rabies, SPBNGA-S, vaccination, V-RG, zoonosis.






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2006 by the Wildlife Disease Association.